跳至主要内容
临床试验/ACTRN12622000404729
ACTRN12622000404729招募中未知

Prospective trial investigating the safety of peripheral vasopressors in pre-hospital and retrieval medicine

Robert Ley Greaves0 个研究点目标入组 400 人开始时间: 2022年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • any patient being transferred by Lifeflight retrieval medicne receiving peripheral vasopressors, including inter facility and pre hospital work.

排除标准

  • -Complication of peripheral vasopressor prior to transfer
  • -Patient not transported by LRM ie clinical improvement or decline precluding transport

研究者

发起方
Robert Ley Greaves

相似试验

已完成
不适用
Confirmatory clinical trial about safeness of perioperative blood glucose management using artificial pancreas in division of hepato-pancreato-biliary surgery1) Hepatectomy above 2 sectors 2) Pansreatoduodenectomy 3) Liver transplantation
JPRN-UMIN000016451Department of Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University45
已完成
不适用
Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitisAcute cholecystitis
JPRN-UMIN000002052Chiba University Graduate School of Medicine78
进行中(未招募)
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1
EUCTR2012-003566-41-BEovo Nordisk A/S346
进行中(未招募)
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861
EUCTR2012-003566-41-SIovo Nordisk A/S346
进行中(未招募)
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1
EUCTR2012-003566-41-HRovo Nordisk A/S346